Publications by authors named "Pierre Combe"

Claim this Profile
P
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer.
Claudia Marchetti, Gwenael Ferron, Olivier Colomban, Diana Giannarelli, Felix Blanc-Durand, Pierre Combe

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome of advanced or recurrent endometrial carcinoma treated with chemotherapy: a French observational retrospective cohort: the ENDOVIE study.
Jerome Alexandre, Philippe Boudier, Elise Lavit, Bernard Asselain, Sheik Emambux, Pierre Combe

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.
Nicole Concin, Ioana Braicu, Pierre Combe, Regina Berger, Isabelle Ray-Coquard

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe).
Florence Joly, Fernando Bazan, Delphine Garbay, Yaelle Ouldbey, Philippe Follana, Pierre Combe

JNCI Cancer Spectr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer-A Multicenter Prospective Study.
Mathilde Cancel, Carine Sauger, Julie Biogeau, Véronique Dardaine-Giraud, Thierry Lecomte, Pierre Combe

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad-spectrum dengue virus detection using the commercial RealStar dengue RT-PCR kit 3.0 (Altona) and an in-house combined real-time RT-PCR assay.
Léa Luciani, Pierre Combe, Franck Touret, Céline Gazin, Raphaëlle Klitting

Heliyon· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Alessandro Parisi, Blandine Delaunay, Giada Pinterpe, Antoine Hollebecque, Jean Frederic Blanc, Pierre Combe

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report of Probable DRESS Syndrome Associated with Ribociclib.
Florian Carneiro, Marine Bove, Frédérique Beau-Salinas, Tevy San, Pierre Combe

Case Rep Oncol Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
Candice Hober, Lisa Fredeau, Anne Pham-Ledard, Marouane Boubaya, Florian Herms, Pierre Combe

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting tumor response and outcome of second-look surgery with F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
Nicolas Aide, Pauline Fauchille, Elodie Coquan, Gwenael Ferron, Pierre Combe

Eur J Nucl Med Mol Imaging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotoxicity Associated With Niraparib.
Hélène Lazareth, Nicolas Delanoy, Raphaël Cohen, Emilie Boissier, Hamza Ayari, Pierre Combe

Am J Kidney Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study).
Patrick Robelin, Michel Tod, Olivier Colomban, Joel Lachuer, Isabelle Ray-Coquard, Pierre Combe

Gynecol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.
Benoit You, Patrick Robelin, Michel Tod, Christophe Louvet, Jean-Pierre Lotz, Pierre Combe

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Pierre Combe

N Engl J Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey].
Marianne Lorcet, Alain Lortholary, Jean Emmanuel Kurtz, Dominique Berton-Rigaud, Michel Fabbro, Pierre Combe

Bull Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryopreserved arterial allografts for in situ reconstruction of abdominal aortic native or secondary graft infection.
Sabrina Ben Ahmed, Adrien Louvancourt, Guillaume Daniel, Pierre Combe, Ambroise Duprey

J Vasc Surg· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
Marie Auvray, Reza Elaidi, Mustafa Ozguroglu, Sermin Guven, Hélène Gauthier, Pierre Combe

Clin Genitourin Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tim-3 Expression on Tumor-Infiltrating PD-1CD8 T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma.
Clémence Granier, Charles Dariane, Pierre Combe, Virginie Verkarre, Saïk Urien

Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
Nicolas Pécuchet, Eleonora Zonta, Audrey Didelot, Pierre Combe, Constance Thibault

PLoS Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA.
Nicolas Pécuchet, Yves Rozenholc, Eleonora Zonta, Daniel Pietrasz, Audrey Didelot, Pierre Combe

Clin Chem· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.
Pierre Combe, Laure Chauvenet, Marie-Aude Lefrère-Belda, Hélène Blons, Caroline Rousseau

Invest New Drugs· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord-Stromal Tumors: A Systematic Review and Meta-analysis.
Nicolas Delanoy, Nicolas Pécuchet, Elizabeth Fabre, Pierre Combe, Karine Juvin

Int J Gynecol Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Olaparib in ovarian cancer with BRCA mutation].
Éric Pujade-Lauraine, Pierre Combe

Bull Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma.
Pierre Combe, Eleonore de Guillebon, Constance Thibault, Clémence Granier, Eric Tartour

Oncoimmunology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.
Thibault Voron, Orianne Colussi, Elie Marcheteau, Simon Pernot, Mevyn Nizard, Pierre Combe

J Exp Med· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis